Claims Reimbursement to Health Care Providers and Facilities for Testing, Treatment, and Vaccine Administration of the Uninsured

The COVID-19 Claims Reimbursement to Health Care Providers and Facilities for Testing, Treatment, and Vaccine Administration for the Uninsured Program provides reimbursements on a rolling basis directly to eligible health care entities for claims that are attributed to the testing, treatment, and or vaccine administration of COVID-19 for uninsured individuals. The program funding information is as follow:

TESTING
The American Rescue Plan Act (ARP) which provided $4.8 billion to reimburse providers for testing the uninsured; the Families First Coronavirus Response Act (FFCRA) Relief Fund, which includes funds received from the Public Health and Social Services Emergency Fund, as appropriated in the FFCRCA (P.L. 116-127) and the Paycheck Protection Program and Health Care Enhancement Act (P.L. 116-139) (PPPHCEA), which each appropriated $1 billion to reimburse health care entities for conducting COVID-19 testing for the uninsured.

TREATMENT & VACCINATION
The Provider Relief Fund, which includes funds received from the Public Health and Social Services Emergency Fund, as appropriated in the Coronavirus Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136), provided $100 billion in relief funds. The PPPHCEA appropriated an additional $75 billion in relief funds and the Coronavirus Response and Relief Supplemental Appropriations (CRRSA) Act (P.L. 116-260) appropriated another $3 billion. Within the Provider Relief Fund, a portion of the funding from these sources will be used to support healthcare-related expenses attributable to the treatment of uninsured individuals with COVID-19 and vaccination of uninsured individuals. To learn more about the program, visit: https://www.hrsa.gov/CovidUninsuredClaim

This dataset represents the list of health care entities who have agreed to the Terms and Conditions and received claims reimbursement for COVID-19 testing of uninsured individuals, vaccine administration and treatment for uninsured individuals with a COVID-19 diagnosis.

For Provider Relief Fund Data - https://data.cdc.gov/Administrative/HHS-Provider-Relief-Fund/kh8y-3es6

《针对无保险人员COVID-19检测、治疗及疫苗接种的医疗保健提供者和设施索赔报销计划》旨在对符合条件的医疗保健实体进行滚动式直接报销，以补偿其因检测、治疗及疫苗接种COVID-19而无保险人员的索赔。该计划的资金信息如下：

检测：美国救援计划法案（ARP）为无保险人员的检测报销提供了48亿美元；家庭首次冠状病毒应对法案（FFCRA）救济基金，包括在FFCRA（P.L. 116-127）和工资保护计划及医疗保健增强法案（PPPHCEA）（P.L. 116-139）中分配的公共卫生和社会服务紧急基金的资金，每个法案分别分配了10亿美元用于报销为无保险人员进行的COVID-19检测。

治疗与疫苗接种：《医疗保健提供者救济基金》包括从冠状病毒援助、救济和经济安全法案（CARES Act）（P.L. 116-136）中获得的资金，该基金提供了1000亿美元的救济资金。PPPHCEA额外分配了750亿美元的救济资金，冠状病毒应对及补充拨款法案（CRRSA） Act（P.L. 116-260）又额外分配了30亿美元。在医疗保健提供者救济基金中，部分资金将从这些来源中用于支持与COVID-19无保险人员治疗及疫苗接种相关的医疗保健费用。欲了解更多关于该计划的信息，请访问：https://www.hrsa.gov/CovidUninsuredClaim

本数据集代表了已同意条款和条件并收到COVID-19无保险人员检测、疫苗接种和治疗索赔报销的医疗保健提供者名单。

有关医疗保健提供者救济基金数据，请访问：https://data.cdc.gov/Administrative/HHS-Provider-Relief-Fund/kh8y-3es6